ÂÜÀòÂÒÂ×

David (Dave) Bailey was appointed by the Board of Directors to serve as the Company’s President and CEO effective June 1, 2021. Dave also serves as a Director on the Board for OrthoPediatrics. He joined OrthoPediatrics in 2007 and has spent most of his career helping build the company from its early start-up days, to a publicly traded company. During his tenure at OP, David has held multiple leadership positions of increasing responsibility, including Domestic and International Sales, Operations and oversight of the Trauma & Deformity Correction and Scoliosis business units. As an early employee in the Company’s life cycle, Dave was instrumental in setting the strategic agenda for OP, raising start-up capital, championing new product development, and establishing a global distribution network. Prior to joining OP Dave worked as a Sales Representative and Independent Distributor for Smith & Nephew Orthopaedics. He attended Purdue University in Lafayette and holds a Bachelor of Science in Sales and Sales Management. He has continued his education at the Harvard Business School, where in 2020, he completed the Professional Leadership Development program.